Selected article for: "past decade and time period"

Author: White, P. Lewis; Price, Jessica S.; Cordey, Alan; Backx, Matthijs
Title: Molecular Diagnosis of Yeast Infections
  • Cord-id: jwjtwqks
  • Document date: 2021_6_18
  • ID: jwjtwqks
    Snippet: PURPOSE OF REVIEW: The use of molecular tests to aid the diagnosis of invasive yeast infection, in particular invasive candidosis, has been described for over two decades, yet widespread application is limited, and diagnosis remains heavily dependent on classical microbiology. This article will review developments from the past decade in attempt to build on existing knowledge. It will highlight clinical performance and limitations while reviewing developments on recognized procedures; it will al
    Document: PURPOSE OF REVIEW: The use of molecular tests to aid the diagnosis of invasive yeast infection, in particular invasive candidosis, has been described for over two decades, yet widespread application is limited, and diagnosis remains heavily dependent on classical microbiology. This article will review developments from the past decade in attempt to build on existing knowledge. It will highlight clinical performance and limitations while reviewing developments on recognized procedures; it will also provide insight into novel approaches incorporated in response to clinical demand (e.g. C. auris and antifungal resistance) or technological advances (e.g. next-generation sequencing). RECENT FINDINGS: Limited methodological standardization and, until recently, unavailability of commercial options have hindered the integration of molecular diagnostics for yeasts. The development of certain, novel commercial methods has received considerable evaluation allowing a greater understanding of individual assay performance, but widespread multicentre evaluation of most commercial kits is lacking. The detection of emerging pathogens (e.g. C. auris) has been enhanced by the development of molecular tests. Molecular methods are providing a better understanding of the mycobiome, mechanisms of resistance and epidemiology/phylogeny. SUMMARY: Despite over two decades of use, the incorporation of molecular methods to enhance the diagnosis of yeast infections remains limited to certain specialist centres. While the development of commercial tests will provide stimulus for broader application, further validation and reduced costs are required. Over the same period of time, Aspergillus PCR has become more widely accepted driven by international efforts to standardize methodology; it is critical that yeast PCR follows suit. Next-generation sequencing will provide significant information on the mycobiome, antifungal resistance mechanism and even broad-range detection directly from the specimen, which may be critical for the molecular detection of yeasts other than Candida species, which is currently limited.

    Search related documents:
    Co phrase search for related documents
    • absence presence and accurate identification: 1, 2, 3
    • absence presence and accurate rapid: 1, 2, 3, 4
    • absence presence and accurate rapid identification: 1
    • absence presence and accurate simple: 1, 2
    • absence presence and accurate timely: 1, 2
    • absence presence and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • absence presence and lod detection: 1
    • absence presence and long appear: 1
    • absence presence and low concentration: 1, 2, 3
    • absence presence and low incidence: 1, 2
    • absence presence and low mortality: 1, 2, 3, 4
    • absence presence and low volume: 1, 2
    • absence presence and luminex xtag: 1
    • absence presence and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • accurate analysis and acute disease: 1
    • accurate analysis and magnetic resonance: 1, 2, 3, 4
    • accurate identification and acid extraction: 1
    • accurate identification and acute disease: 1, 2, 3, 4, 5, 6, 7, 8
    • accurate identification and lod detection: 1